BioSpace News Archive

Vitti Labs, an AATB Accredited Tissue Bank focused on life science research, development, and manufacturing, announced today that the U.S. Food and Drug Administration (FDA) has approved their Investigational New Drug Application (IND) of EV-Pure, an allogenic exosomal product, for women with Primary Ovarian Insufficiency or POI.

APCER Life Sciences, the preferred services provider for Pharmaceutical and Biotech companies looking for compliance solutions across the drug life cycle, has been awarded the ISO 9001:2015 Quality Management System certification.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Amy Broidrick, President and Chief Strategy Officer, and Tariq Arshad, MD, Chief Medical Officer, will present a corporate overview at the LD Micro Main Event XV.

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the creation of the Consortium for Long Read Sequencing (CoLoRS) that aims to accelerate the utility of long-read human genome datasets.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “TELO”) is pleased to announce that it has recently engaged Richard A. Bender MD, FACP, a veteran multiple myeloma (“MM”) clinician, key opinion leader and medical diagnostics expert to establish and chair TELO’s MM clinical advisory board (the “Advisory Board”).

SOHM, Inc., a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces that it has signed a memorandum of understanding with SRAM & MRAM Group for injections of required funds for the Company’s various new pipeline projects.

Promatix, a London-based oncology drug discovery and development company that uses multi-omics to identify novel therapeutics, today announced a collaboration with the laboratory of Professor Jasmin Fisher to develop new proprietary computational executable cancer models for Promatix’s CipherPro suite of algorithms to mine the TxPro databank and identify new oncology drug targets.

China’s research and development industry has recently been flourishing with support from the government’s newer policies and increasing investment

Ventech Solutions is proud to announce that Chief Delivery Officer (CDO) Kathrine Dass is a 2022 Leading for Impact, Women in Leadership Award winner.

Ymmunobio AG, a preclinical stage biotech company specializing in the development of CEACAM (carcinoembryonic antigen-related cell adhesion molecules) antibodies as anti-cancer treatments, has been selected by BIO-Europe 2022 to present at the Start-up Spotlight session on October 25, 2022 in Leipzig, Germany.